Last updated: May 24, 2024
Sponsor: University of Saskatchewan
Overall Status: Completed
Phase
N/A
Condition
Muscular Dystrophy
Sarcopenia
Myasthenia Gravis (Chronic Weakness)
Treatment
Maltodextrin placebo
Whey protein powder
Whole egg powder
Clinical Study ID
NCT05206253
Bio 2962
Ages 18-35 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Resistance training experience for at least one year
Exclusion
Exclusion Criteria:
Having taken any nutritional supplements the past 30 days
Currently using anabolic steroids
Currently taking corticosteroids
Allergies to dairy or egg products
Identifying any medical conditions as determined by the "Get Active Questionnaire"
Study Design
Total Participants: 115
Treatment Group(s): 3
Primary Treatment: Maltodextrin placebo
Phase:
Study Start date:
May 30, 2022
Estimated Completion Date:
August 31, 2023
Study Description
Connect with a study center
University of Regina
Regina, Saskatchewan S4S 0A2
CanadaSite Not Available
University of Saskatchewan
Saskatoon, Saskatchewan S7N5B2
CanadaSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.